
Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Active composition
+1 more active ingredient
Moxifloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Prednisolone binds to glucocorticoid receptors, modulating gene expression and inhibiting the production of pro-inflammatory cytokines.
Medical applications
Imoxtreat-P Eye Drop is a combination ophthalmic solution containing Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic, and Prednisolone 1% w/v, a potent corticosteroid. This formulation is indicated for the treatment of bacterial infections of the eye accompanied by inflammation, such as conjunctivitis, keratitis, and postoperative ocular inflammation. Moxifloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible pathogens. Prednisolone acts by suppressing the inflammatory response, reducing ocular redness, swelling, and discomfort. Imoxtreat-P Eye Drop provides a dual therapeutic approach by simultaneously addressing infection and inflammation, promoting faster recovery and symptom relief. It is intended for topical ophthalmic use and should be administered as directed by a healthcare professional. Caution is advised in patients with known hypersensitivity to fluoroquinolones or corticosteroids, and prolonged use should be avoided to minimize the risk of steroid-induced ocular side effects such as increased intraocular pressure or cataract formation. Proper hygiene should be maintained to prevent contamination of the dropper tip. Imoxtreat-P Eye Drop is contraindicated in viral, fungal, or mycobacterial eye infections unless combined with appropriate antimicrobial therapy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Imoxtreat-P Eye Drop during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Imoxtreat-P Eye Drop during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Imoxtreat-P Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Imoxtreat-P Eye Drop

Moxifloxacin (0.5% w/v) + Prednisolone (1% w/v)
Cheaper alternative availability
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
Active composition
+1 more active ingredient
Moxifloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Prednisolone binds to glucocorticoid receptors, modulating gene expression and inhibiting the production of pro-inflammatory cytokines.
Medical applications
Imoxtreat-P Eye Drop is a combination ophthalmic solution containing Moxifloxacin 0.5% w/v, a broad-spectrum fluoroquinolone antibiotic, and Prednisolone 1% w/v, a potent corticosteroid. This formulation is indicated for the treatment of bacterial infections of the eye accompanied by inflammation, such as conjunctivitis, keratitis, and postoperative ocular inflammation. Moxifloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible pathogens. Prednisolone acts by suppressing the inflammatory response, reducing ocular redness, swelling, and discomfort. Imoxtreat-P Eye Drop provides a dual therapeutic approach by simultaneously addressing infection and inflammation, promoting faster recovery and symptom relief. It is intended for topical ophthalmic use and should be administered as directed by a healthcare professional. Caution is advised in patients with known hypersensitivity to fluoroquinolones or corticosteroids, and prolonged use should be avoided to minimize the risk of steroid-induced ocular side effects such as increased intraocular pressure or cataract formation. Proper hygiene should be maintained to prevent contamination of the dropper tip. Imoxtreat-P Eye Drop is contraindicated in viral, fungal, or mycobacterial eye infections unless combined with appropriate antimicrobial therapy.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Based on clinical trials and patient reports.
Overall Tolerance
Common Side Effects
Information regarding the use of Imoxtreat-P Eye Drop during pregnancy is not available. Please consult your doctor.
High Risk
Information regarding the use of Imoxtreat-P Eye Drop during breastfeeding is not available. Please consult your doctor.
Medical Advice
No interaction found/established
Exercise Caution
Imoxtreat-P Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Imoxtreat-P Eye Drop















